Official confirmation! CFDA joins ICH as its eighth global regulatory body member

Ms. Lindstrom, Executive Chair of the General Assembly of the International Coordination Committee for the Registration of Medicinal Products for Human Use (ICH), announced, "Colleagues of the CFDA (China's State Food and Drug Administration), I think I don't need to explain the applause here. This is your welcome to the CFDA as a member of ICH. We are very pleased to accept the CFDA as a member and look forward to working with them in the future."

Time freezes at this moment. At 16:00 on June 19, Beijing time and 10:00 in Geneva, Switzerland, the headquarters of the State Food and Drug Administration of China and the International Technical Coordination Committee for the Registration of Medicinal Products for Human Use (ICH) released the news at the same time: "The State Food and Drug Administration of China has become a full member of ICH and the 8th member of its global regulatory body." This important event will surely leave a profound mark in the history of China's drug supervision.

Picture Source: ICH Official Website

Picture Source: CFDA official website

Joining the ICH means that China's drug regulatory authorities, pharmaceutical industry and research and development institutions will gradually transform and implement the highest international technical standards and guidelines, and actively participate in the formulation of rules, which will promote the early entry of international innovative drugs into the Chinese market, meet the needs of clinical drugs, and enhance the innovation capacity and international competitiveness of the domestic pharmaceutical industry.